U.S.
International
Log In
Log Out
CNN
Home
Video
Business News
Markets
My Portfolio
Investing
Economy
Tech
Personal Finance
Small Business
Leadership
Premarket
After-hours
Stocks
Market Movers
Dow 30
Bonds
Currencies
Commodities
Mutual Funds
ETFs
World Markets
Alerts
Video
Salix Pharmaceuticals Ltd
(NASDAQ:SLXP)
Add to Watch List
Set Alert
Wednesday’s trading has closed, but SLXP is being traded in the after-hours session.
After-Hours quote »
66.42
Data as of
4:00pm ET
-0.41
/
-0.61%
Today’s Change
37.52
Today
|||
52-Week Range
68.62
+64.11%
Year-to-Date
Quote
Profile
News
Charts
Forecasts
Financials
Shareholders
Competitors
Latest SLXP News
|
Press Releases
MediciNova Presents MN-166 Data - Analyst Blog
5:41pm / Zacks.com
Encouraging Data on Novartis Candidate - Analyst Blog
Jun 10 / Zacks.com
Valeant Raising Funds - Analyst Blog
5:26pm / Zacks.com
Pipeline Progress at Roche - Analyst Blog
Jun 10 / Zacks.com
ViroPharma Up on Takeover Rumors - Analyst Blog
Jun 18 / Zacks.com
Positive Data on Novartis' Afinitor - Analyst Blog
Jun 07 / Zacks.com
AstraZeneca and NGM Collaborate - Analyst Blog
Jun 18 / Zacks.com
BioLineRx Enrolls First Patient in Study - Analyst Blog
Jun 07 / Zacks.com
US Launch of Forest's Namenda XR - Analyst Blog
Jun 17 / Zacks.com
Pfizer in $635 Million Deal - Analyst Blog
Jun 07 / Zacks.com
XOMA Commences Gevokizumab Study - Analyst Blog
Jun 17 / Zacks.com
Impax Reduces Workforce - Analyst Blog
Jun 06 / Zacks.com
Update on UCB Lupus Candidate - Analyst Blog
Jun 13 / Zacks.com
Avanir to Expedite AVP-786 Development - Analyst Blog
Jun 06 / Zacks.com
FDA Panel Meeting for Salix Drug - Analyst Blog
Jun 13 / Zacks.com
Endo to Trim Workforce - Analyst Blog
Jun 06 / Zacks.com
Orphan Drug Status for ViroPharma's Maribavir - Analyst Blog
Jun 12 / Zacks.com
Priority Review for AZN/BMY Drug - Analyst Blog
Jun 06 / Zacks.com
Questcor Surges on Drug Acquisition - Analyst Blog
Jun 12 / Zacks.com
FDA Issues Warning Letter to Novartis - Analyst Blog
Jun 05 / Zacks.com
AstraZeneca to Buy Pearl Therapeutics - Analyst Blog
Jun 11 / Zacks.com
AstraZeneca to Return Fostamatinib Rights - Analyst Blog
Jun 05 / Zacks.com
Tentative Approval for SUPN Candidate - Analyst Blog
Jun 11 / Zacks.com
Astellas' Launch Plans for Acofide - Analyst Blog
Jun 05 / Zacks.com
Update on Gentium's Defibrotide - Analyst Blog
Jun 10 / Zacks.com
My Portfolio
My Watch List
Last 5 Quotes
To view my watchlist
Not a member yet?
Sign up now for a free account
jobs
by
Search for jobs
Search All Jobs from Across the Web
About CNNMoney
Contact Us
Advertise with Us
User Preferences
Career Opportunities
Closed Captioning
Content
Fortune Magazine
Money Magazine
Business News
Markets
Term Sheet
Economy
Tech
Personal Finance
Small Business
Video
Magazines
Subscribe to Fortune
Subscribe to Money
Give the Gift of Fortune
Give the Gift of Money
Reprints
Special Sections
Magazine Customer Service
Conferences
Site Tools
Site Map
Watchlist
Portfolio
Search Jobs
Real Estate Search
Mortgage and Savings Center
Calculators
Corrections
Market Data Alerts
News Alerts
Stay Connected
My Account
Mobile Site & Apps
Facebook
Twitter
LinkedIn
YouTube
RSS Feeds
Newsletters
Tumblr
Google+
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET.
Disclaimer
LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR.
Disclaimer
. Morningstar: © 2013 Morningstar, Inc. All Rights Reserved.
Disclaimer
The Dow Jones Indexes
SM
are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones Indexes
SM
© 2013 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2013. All rights reserved. Most stock quote data provided by BATS.
© 2013 Cable News Network. A Time Warner Company. All Rights Reserved.
Terms
under which this service is provided to you.
Privacy Policy
.
Ad choices
.